DUXAP10 and esophageal squamous cell carcinoma: As shown in KYSE30 and KYSE180 ESCC (Wang et al., 2018) cells, DUXAP10 has been similarly confirmed to modulate the processes of cell proliferation and apoptosis by negatively modulating p21 expression by interacting with zeste homolog 2 (EZH2).